COMPUTATIONAL BIOLOGY MARKET ANALYSIS

Computational Biology Market, By Type (Cellular and Biological Simulation (Computational Genomics, Computational Proteomics, Pharmacogenomics, and Others (Transcriptomics/Metabolomic)), Disease Modeling and Simulation Applications (Drug Discovery, Drug Development)), By Tools (Content/Database, Analysis Software and Services, and IT Infrastructure (Hardware)),and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -

Published In : Mar 2025
Code : CMI3915
Pages :160
Formats :
Excel and PDF
Industry : Healthcare IT

Market News

Global Computational Biology Market: Key Developments

On October 14, 2020, Summit Biolabs, a U.S.-based medical laboratory announced a broad strategic collaboration involving the research, development, and commercialization of saliva liquid-biopsy tests for early cancer detection and diagnosis of COVID-19 and other viral contagions with Colorado Center for Personalized Medicine, a U.S.-based biorepository. This collaboration broadened and strengthened Summit Biolabs’ ability to bring saliva liquid-biopsy tests to enable better treatment and improved outcomes for patients.

On June 24, 2020, AsclepiX Therapeutics, Inc., a U.S.-based biotechnology company, announced that it has closed a US$ 35 million Series A financing led by Perceptive Xontogeny Venture Fund. The proceeds from financing will fund Phase 1/2a clinical trials of AXT107, the company’s investigational drug.

On January 20, 2022, Researchers from the University of Illinois at Urbana-Champaign, a U.S.-based research university, developed Graphics Processing Unit (GPU)-accelerated software to simulate a 2-billion-atom cell that metabolizes and shows growth similar that of a living cell in the body. The model uses NVIDIA, a U.S.-based technology company’s product, GPUs to simulate 7,000 genetic information processes over a 20-minute span of the cell cycle.

On November 10, 2020, PerkinElmer Inc., a U.S.-based pharmaceutical products company, announced the release of ChemDraw and ChemOffice+ Cloud version 20.0, a Research Suite designed to help researchers bring their chemistry to life and quickly turn it into actionable chemical knowledge.